Pfizer ends its COVID-19 vaccine trial with a 95% success rate
Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday.
Continue Reading https://uk.reuters.com
Join the Discussion